Aimed Alliance Urges Patient-Centered, Evidence-Based Reviews by Maryland PDAB
Prior to the Board’s July meeting to conduct cost affordability reviews for Farxiga and Jardiance,…
Browsing: Federal
Aimed Alliance Urges Caution for UPL Implementation in Maryland
On July 27, 2026, Aimed Alliance sent a letter to the Maryland Prescription Drug Affordability…
Senators Introduce Legislation Prioritizing Ethical Implications of AI
On July 23, 2026, Senators Ted Cruz (R-Texas) and Raphael Warnock (D-Georgia) introduced the Human…
U.S. Launches Investigation into German Drug Pricing
The U.S. Trade Office has announced it is opening an investigation into Germany over its…
Stakeholders Renew Push to Finalize 2021 HIPAA Rule as Digital Health Priorities Elevate Its Importance
Health app developers and patient advocates are urging the Trump administration to finalize a long-pending…
Aimed Alliance Comments on CMS’s Essential Health Benefits RFI
On July 14, 2026, Aimed Alliance submitted a comment to the Department of Health and…
Aimed Alliance Urges Colorado PDAB Not to Establish a UPL for Cosentyx
On June 24, Aimed Alliance sent a letter to the Colorado Prescription Drug Affordability Board…
Aimed Alliance Pushes for Expanding Specialized Access for Adults with Rare Diseases in Massachusetts
On June 15, 2026, Aimed Alliance, alongside KIF1A.ORG, sent a letter to the Massachusetts Division…
Aimed Alliance Comments on Proposed CMS Rule Regarding Electronic Prior Authorization
On June 15, 2026, Aimed Alliance sent a letter to the Centers for Medicare &…
Aimed Alliance Releases New Report on the Evolving Landscape of State AI Policy
On June 16, 2026, Aimed Alliance released its latest publication, Guardrails for Care: AI and…